Quercetin 3-rhamnoside exerts antiinfluenza A virus activity in mice

Phytotherapy Research

Volumn 26, Issue 3, 2012, Pages 462-464

  Choi, Hwa Jung ^a   Song, Jae Hyoung ^b   Kwon, Dur Han ^c  

^a Daejeon Health Sciences College   (South Korea)

^b Wonkwang University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Histological evaluation; Influenza; Mouse model; Quercetin 3 rhamnoside

Indexed keywords

OSELTAMIVIR; PLACEBO; QUERCITRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HISTOPATHOLOGY; IN VIVO STUDY; INFLUENZA; INFLUENZA VIRUS A; INTERSTITIAL PNEUMONIA; LUNG EDEMA; MALE; NONHUMAN; PROCESS DEVELOPMENT; RAT; VIRAL BRONCHIOLITIS; WEIGHT REDUCTION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DOGS; INFLUENZA A VIRUS; LUNG; MALE; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; OSELTAMIVIR; PHYTOTHERAPY; QUERCETIN; VIRAL LOAD; VIRUS CULTIVATION; WEIGHT LOSS;

MUS; ORTHOMYXOVIRIDAE;

EID: 84858007261     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3529     Document Type: Article

References (10)

1. Choi HJ, Kim JH, Lee CH et al. 2009a. Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus. Antiviral Res 81: 77-81.
2. Choi HJ, Song JH, Baek SH, Kwon DH. 2009b. Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication. Eur J Pharm Sci 37: 329-333.
3. Colman PM. 1994. Influenza virus neuraminidase: structure, antibodies, and inhibitors. Protein Sci 3: 1687-1696. (Pubitemid 24356591)
4. Droebner K, Ehrhardt C, Poetter A, Ludwig S, Planz O. 2007. CYSTUS052, a polyphenol-rich plant extract, exerts antiinfluenza virus activity in mice. Antiviral Res 76:1-10. (Pubitemid 47176688)
5. Gubareva LV, Matrosovich MN, Brenner MK, Bethell RC, Webster RG. 1998. Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis 178: 1257-1262.
6. Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. 2003. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Int Med 163: 1667-1672. (Pubitemid 36898954)
7. Ölschlaäger V, Pleschka S, Fisher T et al. 2004. Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice. Oncogene 23: 6639-6646. (Pubitemid 39265527)
8. Palamara AT, Nencioni L, Aquilano K et al. 2005. Inhibition of influenza A virus replication by resveratrol. J Infect Dis 191: 1719-1729. (Pubitemid 40656761)
9. World Health Organization. 2004. Influenza: Report by the Secretariat. World Health Assembly WHO: Geneva, A23-A56.
10. Yen HL, Monto AS, Webster RG, Govorkova EA. 2005. Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. J Infect Dis 192: 665-672.